FDA Approves First New Fibromyalgia Treatment in Over 16 Years
TL;DR Summary
The FDA has approved Tonmya, a new treatment for fibromyalgia developed by Tonix Pharmaceuticals, marking the first new FDA-approved fibromyalgia drug in over 15 years. The drug is a once-daily sublingual tablet shown to significantly reduce pain in clinical trials. Following the announcement, Tonix's stock initially surged but then declined, reflecting market volatility and investor reactions.
- FDA Approves New Fibromyalgia Drug, Tonix Shares Climb Investor's Business Daily
- FDA approves Tonix’s Tonmya to treat fibromyalgia Yahoo Finance
- US FDA approves Tonix Pharma's drug to manage pain related to chronic condition Reuters
- FDA approves landmark fibromyalgia drug that works like no other New Atlas
- With FDA nod, Tonix's Tonmya becomes first new fibromyalgia treatment in more than 16 years Fierce Pharma
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
2 min
vs 3 min read
Condensed
87%
417 → 56 words
Want the full story? Read the original article
Read on Investor's Business Daily